{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:00:56Z","timestamp":1790535656508,"version":"4.1.0"},"reference-count":119,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J7-2594"],"award-info":[{"award-number":["J7-2594"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0108"],"award-info":[{"award-number":["P3-0108"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P1-0198"],"award-info":[{"award-number":["P1-0198"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["Young-researcher funding"],"award-info":[{"award-number":["Young-researcher funding"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRIC UL","award":["IP-0510 Infrastructure program."],"award-info":[{"award-number":["IP-0510 Infrastructure program."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Urinary tract infections (UTIs) represent a serious global health issue, especially due to emerging multidrug-resistant UTI-causing bacteria. Recently, we showed that the human amniotic membrane (hAM) could be a candidate for treatments and prevention of UPEC and Staphylococcus aureus infections. However, its role against multidrug-resistant bacteria, namely methicillin-resistant S. aureus (MRSA), extended-spectrum beta-lactamases (ESBL) producing Escherichia coli and Klebsiella pneumoniae, vancomycin-resistant Enterococci (VRE), carbapenem-resistant Acinetobacter baumannii, and Pseudomonas aeruginosa has not yet been thoroughly explored. Here, we demonstrate for the first time that the hAM homogenate had antibacterial activity against 7 out of 11 tested multidrug-resistant strains, the greatest effect was on MRSA. Using novel approaches, its activity against MRSA was further evaluated in a complex microenvironment of normal and cancerous urinary bladder urothelia. Even short-term incubation in hAM homogenate significantly decreased the number of bacteria in MRSA-infected urothelial models, while it did not affect the viability, number, and ultrastructure of urothelial cells. The hAM patches had no antibacterial activity against any of the tested strains, which further exposes the importance of the hAM preparation. Our study substantially contributes to basic knowledge on the antibacterial activity of hAM and reveals its potential to be used as an antibacterial agent against multidrug-resistant bacteria.<\/jats:p>","DOI":"10.3390\/biomedicines9020218","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T13:17:02Z","timestamp":1613827022000},"page":"218","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Antibacterial Activity of Human Amniotic Membrane against Multidrug-Resistant Bacteria Associated with Urinary Tract Infections: New Insights from Normal and Cancerous Urothelial Models"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3672-7159","authenticated-orcid":false,"given":"Taja \u017deleznik","family":"Ramuta","sequence":"first","affiliation":[{"name":"Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-0137","authenticated-orcid":false,"given":"Larisa","family":"Tratnjek","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9303-1903","authenticated-orcid":false,"given":"Aleksandar","family":"Janev","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4126-7644","authenticated-orcid":false,"given":"Katja","family":"Seme","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-165X","authenticated-orcid":false,"given":"Marjanca","family":"Star\u010di\u010d Erjavec","sequence":"additional","affiliation":[{"name":"Department of Biology, Biotechnical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-573X","authenticated-orcid":false,"given":"Mateja Erdani","family":"Kreft","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pop.2018.05.005","article-title":"Urinary Tract Infection Antibiotic Resistance in the United States","volume":"45","author":"Waller","year":"2018","journal-title":"Prim. Care Clin. Off. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Morris, S., and Cerceo, E. (2020). Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting. Antibiotics, 9.","DOI":"10.3390\/antibiotics9040196"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Medina, M., and Castillo-Pino, E. (2019). An introduction to the epidemiology and burden of urinary tract infections. Ther. Adv. Urol., 11.","DOI":"10.1177\/1756287219832172"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jgar.2018.11.004","article-title":"Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia","volume":"17","author":"Ny","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s10096-019-03655-3","article-title":"Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period","volume":"38","author":"Notermans","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Walker","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/1120009X.2017.1380395","article-title":"Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: A review","volume":"29","author":"Mazzariol","year":"2017","journal-title":"J. Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12941-018-0286-5","article-title":"An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: Cross-sectional study","volume":"17","author":"Harel","year":"2018","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"van Driel, A. (2020). Antibiotic resistance of uropathogenic Escherichia coli and ESBL prevalence in general practice patients over 10 years. Br. J. Gen. Pr., 70.","DOI":"10.3399\/bjgp20X711533"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2016.01.008","article-title":"Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010\u20132013","volume":"47","author":"Jean","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jiac.2017.11.013","article-title":"Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU)","volume":"24","author":"Choe","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/jgid.jgid_104_17","article-title":"State of the Globe: Rising Antimicrobial Resistance of Pathogens in Urinary Tract Infection","volume":"10","author":"Paul","year":"2018","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Munita, J.M., and Arias, C.A. (2016). Mechanisms of Antibiotic Resistance. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.VMBF-0016-2015"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist. Updates"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrmicro3155","article-title":"Ribosome-targeting antibiotics and mechanisms of bacterial resistance","volume":"12","author":"Wilson","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10156-013-0640-7","article-title":"The ABCD\u2019s of \u03b2-lactamase nomenclature","volume":"19","author":"Bush","year":"2013","journal-title":"J. Infect. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tim.2011.09.005","article-title":"The emerging NDM carbapenemases","volume":"19","author":"Nordmann","year":"2011","journal-title":"Trends Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrmicro1994","article-title":"The porin and the permeating antibiotic: A selective diffusion barrier in Gram-negative bacteria","volume":"6","author":"James","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.micro.56.012302.160310","article-title":"Function of Pseudomonas porins in uptake and efflux","volume":"56","author":"Hancock","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jac\/dki171","article-title":"Efflux-mediated antimicrobial resistance","volume":"56","author":"Poole","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.19.2.382-402.2006","article-title":"Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria","volume":"19","author":"Piddock","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.1208037109","article-title":"Structural basis for TetM-mediated tetracycline resistance","volume":"109","author":"Franckenberg","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/cr030112j","article-title":"Rifamycin-mode of action, resistance, and biosynthesis","volume":"105","author":"Floss","year":"2005","journal-title":"Chem. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2014.04.002","article-title":"Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms","volume":"17","author":"Mendes","year":"2014","journal-title":"Drug Resist. Updat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1574-6968.2008.01145.x","article-title":"Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes","volume":"282","author":"Roberts","year":"2008","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","article-title":"Mechanisms of antibiotic resistance in enterococci","volume":"12","author":"Miller","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.idc.2016.02.006","article-title":"Vancomycin-Resistant Enterococci: Therapeutic Challenges in the 21st Century","volume":"30","author":"Miller","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ab.2013.07.045","article-title":"A liquid chromatography-tandem mass spectrometry assay for d-Ala-d-Lac: A key intermediate for vancomycin resistance in vancomycin-resistant enterococci","volume":"442","author":"Putty","year":"2013","journal-title":"Anal. Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biochi.2015.11.017","article-title":"Cytoplasmic peptidoglycan intermediate levels in Staphylococcus aureus","volume":"121","author":"Vemula","year":"2016","journal-title":"Biochimie"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vemula, H., Ayon, N.J., Burton, A., and Gutheil, W.G. (2017). Antibiotic Effects on Methicillin-Resistant Staphylococcus aureus Cytoplasmic Peptidoglycan Intermediate Levels and Evidence for Potential Metabolite Level Regulatory Loops. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.02253-16"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus: Role of the cell membrane and cell wall","volume":"1277","author":"Bayer","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial Resistance: Implications and Costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, V.P., Hannan, T.J., Nielsen, H.V., and Hultgren, S.J. (2016). Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.UTI-0013-2012"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.17305\/bjbms.2018.3826","article-title":"Analysis of multidrug-resistant bacteria in 3223 patients with hospital-acquired infections (HAI) from a tertiary general hospital in China","volume":"19","author":"Wang","year":"2019","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e4635","DOI":"10.1097\/MD.0000000000004635","article-title":"Methicillin-resistant Staphylococcus aureus as a uropathogen in an Irish setting","volume":"96","author":"Looney","year":"2017","journal-title":"Medicine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4111\/kju.2014.55.5.349","article-title":"Unexpected Multidrug Resistance of Methicillin-Resistant Staphylococcus aureus in Urine Samples: A Single-Center Study","volume":"55","author":"Lunacek","year":"2014","journal-title":"Korean J. Urol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s101560200029","article-title":"Molecular epidemiological studies of Staphylococcus aureus in urinary tract infection","volume":"8","author":"Araki","year":"2002","journal-title":"J. Infect. Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0974-7796.130536","article-title":"Extended-spectrum \u03b2-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time","volume":"6","author":"Picozzi","year":"2014","journal-title":"Urol. Ann."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3201\/eid1511.081501","article-title":"Persistent extended-spectrum \u03b2-lactamase urinary tract infection","volume":"15","author":"DeBusscher","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/0974-7796.130543","article-title":"Complicated urinary tract infection caused by extended spectrum \u03b2-lactamase-producing Escherichia coli","volume":"6","author":"Ranjan","year":"2014","journal-title":"Urol. Ann."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Caneiras, C., Lito, L., Melo-Cristino, J., and Duarte, A. (2019). Community- and Hospital-Acquired Klebsiella pneumoniae Urinary Tract Infections in Portugal: Virulence and Antibiotic Resistance. Microorganisms, 7.","DOI":"10.3390\/microorganisms7050138"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/AAC.02445-13","article-title":"Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria","volume":"58","author":"Qureshi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Guerra, G., Heras-Ca\u00f1as, V., Guti\u00e9rrez-Soto, M., Aznarte-Padial, M.D.P., Exp\u00f3sito-Ruiz, M., Navarro-Mar\u00ed, J.M., and Guti\u00e9rrez-Fern\u00e1ndez, J. (2018). Urinary tract infection by Acinetobacter baumannii and Pseudomonas aeruginosa: Evolution of antimicrobial resistance and therapeutic alternatives. J. Med. Microbiol.","DOI":"10.1099\/jmm.0.000742"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/s41467-019-10706-y","article-title":"Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes","volume":"10","author":"Calix","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Moubareck, C.A., and Halat, D.H. (2020). Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics, 9.","DOI":"10.3390\/antibiotics9030119"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1592\/phco.30.11.1136","article-title":"Vancomycin-resistant enterococcal urinary tract infections","volume":"30","author":"Heintz","year":"2010","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/IDR.S54125","article-title":"Vancomycin-resistant enterococcal infections: Epidemiology, clinical manifestations, and optimal management","volume":"8","author":"Crank","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4111\/icu.2016.57.2.129","article-title":"Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom","volume":"57","author":"Toner","year":"2016","journal-title":"Investig. Clin. Urol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Lamas Ferreiro, J.L., \u00c1lvarez Otero, J., Gonz\u00e1lez Gonz\u00e1lez, L., Novoa Lamazares, L., Arca Blanco, A., Berm\u00fadez Sanjurjo, J.R., Rodr\u00edguez Conde, I., Fern\u00e1ndez Soneira, M., and de la Fuente Aguado, J. (2017). Pseudomonas aeruginosa urinary tract infections in hospitalized patients: Mortality and prognostic factors. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178178"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2147\/IDR.S185753","article-title":"Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: A retrospective multicenter cohort study","volume":"11","author":"Gomila","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Mamede, A.C., and Botelho, M.F. (2015). Biochemical Properties of Amniotic Membrane. Amniotic Membrane, Springer.","DOI":"10.1007\/978-94-017-9975-1"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fbioe.2015.00162","article-title":"The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine","volume":"3","author":"Silini","year":"2015","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.placenta.2015.08.015","article-title":"Different metabolic activity in placental and reflected regions of the human amniotic membrane","volume":"36","author":"Banerjee","year":"2015","journal-title":"Placenta"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/17460751.4.2.275","article-title":"Amniotic membrane and amniotic fluid-derived cells: Potential tools for regenerative medicine?","volume":"4","author":"Parolini","year":"2009","journal-title":"Regen. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1076\/0271-3683(200003)2031-9FT173","article-title":"Growth factor mRNA and protein in preserved human amniotic membrane","volume":"20","author":"Koizumi","year":"2000","journal-title":"Curr. Eye Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/term.2069","article-title":"Amniotic epithelial cells promote wound healing in mice through high epithelialization and engraftment","volume":"10","author":"Jin","year":"2015","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1089\/ten.tea.2008.0432","article-title":"Epidermal growth factor variations in amniotic membrane used for ex vivo tissue constructs","volume":"15","author":"Gicquel","year":"2009","journal-title":"Tissue Eng. Part A"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/02713680701459441","article-title":"The expression of TIMPs in cryo-preserved and freeze-dried amniotic membrane","volume":"32","author":"Koh","year":"2007","journal-title":"Curr. Eye Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biomaterials.2009.09.034","article-title":"Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction","volume":"31","author":"Riau","year":"2010","journal-title":"Biomaterials"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3727\/096368916X692645","article-title":"Antifibrotic Effects of Human Amniotic Membrane Transplantation in Established Biliary Fibrosis Induced in Rats","volume":"25","author":"SantAnna","year":"2016","journal-title":"Cell Transpl."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.0.CO;2-X","article-title":"Suppression of transforming growth factor-\u03b2 isoforms, TGF-\u03b2 receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix","volume":"179","author":"Tseng","year":"1999","journal-title":"J. Cell Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1634\/stemcells.2007-0491","article-title":"Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities","volume":"26","author":"Magatti","year":"2008","journal-title":"Stem Cells"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3727\/096368914X684033","article-title":"Human Amniotic Membrane-Derived Mesenchymal and Epithelial Cells Exert Different Effects on Monocyte-Derived Dendritic Cell Differentiation and Function","volume":"24","author":"Magatti","year":"2015","journal-title":"Cell Transplant."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Magatti, M., Vertua, E., De Munari, S., Caro, M., Caruso, M., Silini, A., Delgado, M., and Parolini, O. (2016). Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features. J. Tissue Eng. Regen. Med.","DOI":"10.1002\/term.2193"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0963689717742819","article-title":"The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin","volume":"27","author":"Magatti","year":"2018","journal-title":"Cell Transplant."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.humimm.2008.04.007","article-title":"Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells","volume":"69","author":"Banas","year":"2008","journal-title":"Hum. Immunol."},{"key":"ref_70","first-page":"53","article-title":"Amniotic membrane-derived stem cells: Immunomodulatory properties and potential clinical application","volume":"7","author":"Insausti","year":"2014","journal-title":"Stem Cells Cloning Adv. Appl."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1167\/iovs.04-0495","article-title":"Immunosuppressive factors secreted by human amniotic epithelial cells","volume":"46","author":"Li","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1582-4934.2012.01531.x","article-title":"Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest","volume":"16","author":"Magatti","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.mehy.2013.08.018","article-title":"Inhibition of HSP90 could be possible mechanism for anti-cancer property of amniotic membrane","volume":"81","author":"Niknejad","year":"2013","journal-title":"Med. Hypotheses"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcyt.2013.07.005","article-title":"Human amniotic epithelial cells induce apoptosis of cancer cells: A new anti-tumor therapeutic strategy","volume":"16","author":"Niknejad","year":"2014","journal-title":"Cytotherapy"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00441-016-2364-3","article-title":"Induction of apoptosis, stimulation of cell-cycle arrest and inhibition of angiogenesis make human amnion-derived cells promising sources for cell therapy of cancer","volume":"363","author":"Niknejad","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3892\/ijo.2017.4123","article-title":"Human amniotic epithelial cells inhibit growth of epithelial ovarian cancer cells via TGF-\u03b21-mediated cell cycle arrest","volume":"51","author":"Bu","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"14193","DOI":"10.1038\/s41598-019-50648-5","article-title":"Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells","volume":"9","author":"Riedel","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00232-014-9642-3","article-title":"Effect of amniotic membrane proteins in human cancer cell lines: An exploratory study","volume":"247","author":"Mamede","year":"2014","journal-title":"J. Membr. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12032-015-0702-z","article-title":"Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma","volume":"32","author":"Mamede","year":"2015","journal-title":"Med. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12253-016-0053-x","article-title":"Oxidative Stress, DNA, Cell Cycle\/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma","volume":"22","author":"Mamede","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2020.554530","article-title":"The Cells and Extracellular Matrix of Human Amniotic Membrane Hinder the Growth and Invasive Potential of Bladder Urothelial Cancer Cells","volume":"8","author":"Ramuta","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fmicb.2020.00469","article-title":"Amniotic Membrane Preparation Crucially Affects Its Broad-Spectrum Activity Against Uropathogenic Bacteria","volume":"11","author":"Ramuta","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.2147\/IDR.S215006","article-title":"Different Effects Of Amniotic Membrane Homogenate On The Growth Of Uropathogenic Escherichia coli, Staphylococcus aureus and Serratia marcescens","volume":"12","author":"Ramuta","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3389\/fmicb.2017.01948","article-title":"Antimicrobial and Antibiofilm Effects of Human Amniotic\/Chorionic Membrane Extract on Streptococcus pneumoniae","volume":"8","author":"Yadav","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"13722","DOI":"10.1038\/s41598-017-13310-6","article-title":"Antimicrobial Peptides Secreted From Human Cryopreserved Viable Amniotic Membrane Contribute to its Antibacterial Activity","volume":"7","author":"Mao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0301-2115(00)00345-6","article-title":"Antibacterial properties of human amnion and chorion in vitro","volume":"94","author":"Kjaergaard","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/s41598-017-17210-7","article-title":"Induction of antimicrobial peptides secretion by IL-1\u03b2 enhances human amniotic membrane for regenerative medicine","volume":"7","author":"Tehrani","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00418-011-0893-0","article-title":"Hyperplasia as a mechanism for rapid resealing urothelial injuries and maintaining high transepithelial resistance","volume":"137","author":"Kocbek","year":"2012","journal-title":"Histochem. Cell Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00418-014-1265-3","article-title":"The complete functional recovery of chitosan-treated biomimetic hyperplastic and normoplastic urothelial models","volume":"143","author":"Kreft","year":"2015","journal-title":"Histochem. Cell Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.tiv.2017.08.008","article-title":"Chitosan hydrochloride has no detrimental effect on bladder urothelial cancer cells","volume":"44","author":"Jerman","year":"2017","journal-title":"Toxicol. Vitr."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Lojk, J., Bregar, V.B., Strojan, K., Hudoklin, S., Verani\u010d, P., Pavlin, M., and Kreft, M.E. (2017). Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells. Histochem. Cell Biol.","DOI":"10.1007\/s00418-017-1605-1"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/ten.tec.2013.0298","article-title":"Amniotic membrane scaffolds enable the development of tissue-engineered urothelium with molecular and ultrastructural properties comparable to that of native urothelium","volume":"20","author":"Jerman","year":"2014","journal-title":"Tissue Eng. Part C Methods"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jsps.2018.02.023","article-title":"Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review","volume":"26","author":"Tenney","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Milovanovic, T., Dumic, I., Veli\u010dkovic, J., Lalosevic, M.S., Nikolic, V., and Palibrk, I. (2019). Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: Single center experience in Serbia. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-3761-5"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0143-4004(91)90010-D","article-title":"Antibacterial properties of human amniotic membranes","volume":"12","author":"Talmi","year":"1991","journal-title":"Placenta"},{"key":"ref_97","first-page":"23","article-title":"Human cryopreserved viable amniotic membrane inhibits the growth of bacteria associated with chronic wounds","volume":"8","author":"Mao","year":"2016","journal-title":"J. Diabet. Foot Complicat."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cryobiol.2013.08.010","article-title":"The effects of preservation procedures on antibacterial property of amniotic membrane","volume":"67","author":"Tehrani","year":"2013","journal-title":"Cryobiology"},{"key":"ref_99","first-page":"140","article-title":"Evaluation of anti-bacterial effects of chorionic membranes in vitro","volume":"19","author":"Lessani","year":"2012","journal-title":"J. Birjand Univ. Med Sci."},{"key":"ref_100","first-page":"4533","article-title":"Epithelium of human fresh amniotic membrane has antimicrobial effects in vitro","volume":"6","author":"Wang","year":"2012","journal-title":"Afr. J. Microbiol. Res."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Mao, Y., Singh-Varma, A., Hoffman, T., Dhall, S., Danilkovitch, A., and Kohn, J. (2018). The Effect of Cryopreserved Human Placental Tissues on Biofilm Formation of Wound-Associated Pathogens. J. Funct. Biomater., 9.","DOI":"10.3390\/jfb9010003"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.placenta.2006.01.006","article-title":"Expression of natural antimicrobials by human placenta and fetal membranes","volume":"28","author":"King","year":"2007","journal-title":"Placenta"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri1860","article-title":"Defensins in innate antiviral immunity","volume":"6","author":"Klotman","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0897.1997.tb00511.x","article-title":"Detection of human defensins in the placenta","volume":"38","author":"Svinarich","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.ajog.2004.03.081","article-title":"The novel antimicrobial peptide \u03b23-defensin is produced by the amnion: A possible role of the fetal membranes in innate immunity of the amniotic cavity","volume":"191","author":"Buhimschi","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1677\/joe.0.1610299","article-title":"Secretory leukocyte protease inhibitor concentration increases in amniotic fluid with the onset of labour in women: Characterization of sites of release within the uterus","volume":"161","author":"Denison","year":"1999","journal-title":"J. Endocrinol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1477-7827-10-70","article-title":"Tissue-specific human \u03b2-defensins (HBD)-1, HBD-2 and HBD-3 secretion profile from human amniochorionic membranes stimulated with Candida albicans in a two-compartment tissue culture system","volume":"10","author":"Ruiz","year":"2012","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_108","first-page":"545","article-title":"Antimicrobial Activity of Human Amniotic and Chorionic Membranes","volume":"2","author":"Parthasarathy","year":"2014","journal-title":"J. Acad. Ind. Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Voidazan, S., Albu, S., Toth, R., Grigorescu, B., Rachita, A., and Moldovan, I. (2020). Healthcare Associated Infections\u2014A New Pathology in Medical Practice?. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17030760"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Pana, Z.D., and Zaoutis, T. (2018). Treatment of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae (ESBLs) infections: What have we learned until now?. F1000Research, 7.","DOI":"10.12688\/f1000research.14822.1"},{"key":"ref_111","unstructured":"Wilke, M., Worf, K., Preisend\u00f6rfer, B., Heinlein, W., Kast, T., and Bodmann, K.F. (2019). Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment\u2014A health economic analysis using German DRG data. GMS Infect. Dis., 7."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5301\/uro.5000092","article-title":"Nosocomial urinary tract infections: A review","volume":"81","author":"Iacovelli","year":"2014","journal-title":"Urol. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/498518","article-title":"Isolation of Staphylococcus aureus from the urinary tract: Association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia","volume":"42","author":"Muder","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"625","DOI":"10.15585\/mmwr.mm6722a2","article-title":"Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs\u2014Six Sites, 2005\u20132016","volume":"67","author":"Jackson","year":"2018","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.euf.2018.11.003","article-title":"Management of Urosepsis in 2018","volume":"5","author":"Bonkat","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopha.2018.12.119","article-title":"Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth","volume":"111","author":"Yadav","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Jerman, U.D., Verani\u010d, P., Cirman, T., and Kreft, M.E. (2020). Human Amniotic Membrane Enriched with Urinary Bladder Fibroblasts Promote the Re-Epithelization of Urothelial Injury. Cell Transplant., 29.","DOI":"10.1177\/0963689720946668"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Perdikouri, E.I.A., Arvaniti, K., Lathyris, D., Kiouti, F.A., Siskou, E., Haidich, A.B., and Papandreou, C. (2019). Infections Due to Multidrug-Resistant Bacteria in Oncological Patients: Insights from a Five-Year Epidemiological and Clinical Analysis. Microorganisms, 7.","DOI":"10.3390\/microorganisms7090277"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Ramuta, T.\u017d., Tratnjek, L., Janev, A., Seme, K., Star\u010di\u010d Erjavec, M., and Kreft, M.E. (2021). Analysis of the antibacterial activity of the human amniotic membrane homogenate against multidrug-resistant bacteria employing normal and cancerous urothelial models. Protocols.io.","DOI":"10.3390\/biomedicines9020218"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/2\/218\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:27:03Z","timestamp":1760160423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/2\/218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,20]]},"references-count":119,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["biomedicines9020218"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9020218","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,20]]}}}